These data suggest the presence of two barriers to tumor progression: (1) the DDR, that would be activated already by a limited replicative stress; and (2) ARF that would require the cross of a higher stress threshold usually supported by multiple oncogene activation. The gene discussed is CDKN2A; the disease is neoplasm.